New Delhi. American pharma company Pfizer is now going to conduct a large-scale trial of its vaccine in children under the age of 12. Pfizer mentioned on Tuesday that on this examine, 4,500 children will be examined at greater than 90 scientific websites in the US, Finland, Poland and Spain. According to the information printed in the information company Reuters, preparations for the trial in younger children have been accomplished.
Keeping in thoughts the tolerance and security of children, in the first section, after giving two doses in the trial performed on 144 children, their immunity has been studied. After the immunity response acquired throughout this time, Pfizer mentioned that now the company will test a dose of 10 micrograms in children aged 5 to 11 years and three micrograms on children in the age group of 6 months to five years.
excellent news coming quickly
A Pfizer spokesperson mentioned the company expects knowledge on children ages 5 to 11 in September and will probably ask drug regulators in related international locations for emergency use of the vaccine later that month. He mentioned that knowledge for children of two to five years can also come quickly.
Experts of Pfizer imagine that the knowledge of the trial performed on children aged 5 to 11 years will come by September. At the identical time, the knowledge of children in the age group of 6 months to 2 years could be discovered anytime in October or November this 12 months. After this, an software will be made for the approval of emergency use for this age group additionally.
Children over 12 years of age already getting vaccine
Pfizer’s Kovid vaccine has already been authorized in the European Union to be used in children over the age of 12. However, this approval has been given for emergency use solely. Pfizer made this vaccine of Corona in collaboration with its German associate BioNtech. The vaccine of this company was first authorized by the World Health Organization (WHO).
At the identical time, in the US and Canada, Pfizer’s vaccine has been given exemption to be used in the age group above 12 years. Then the pharma company had mentioned that the impact of its vaccine in children has been very constructive and no negative effects have been seen in under-trial children.
Several firms proceed
Last month AstraZeneca began a examine in the UK on children aged 6 to 17 years. Johnson & Johnson can also be learning. China’s Sinovac can also be concerned on this race. At the identical time, the focus of Moderna is at the moment on the vaccine test being performed on 12-17 12 months olds, whose outcomes could be revealed quickly.